Document_and_Entity_Informatio
Document and Entity Information | 9 Months Ended | |
Oct. 31, 2014 | Dec. 01, 2014 | |
Document And Entity Information | ' | ' |
Entity Registrant Name | 'GOLDEN OPPORTUNITIES CORPORATION | ' |
Entity Central Index Key | '0001317839 | ' |
Document Type | '10-Q | ' |
Document Period End Date | 31-Oct-14 | ' |
Amendment Flag | 'false | ' |
Current Fiscal Year End Date | '--01-31 | ' |
Is Entity a Well-known Seasoned Issuer? | 'No | ' |
Is Entity a Voluntary Filer? | 'No | ' |
Is Entity's Reporting Status Current? | 'Yes | ' |
Entity Filer Category | 'Smaller Reporting Company | ' |
Entity Common Stock, Shares Outstanding | ' | 33,570,000 |
Document Fiscal Period Focus | 'Q3 | ' |
Document Fiscal Year Focus | '2015 | ' |
BALANCE_SHEETS
BALANCE SHEETS (USD $) | Oct. 31, 2014 | Jan. 31, 2014 |
CURRENT ASSETS | ' | ' |
Cash | $15 | $91 |
Total Current Assets | 15 | 91 |
TOTAL ASSETS | 15 | 91 |
CURRENT LIABILITIES | ' | ' |
Accrued expenses | 1,615 | 1,540 |
Shareholder advances | 14,442 | 7,500 |
Total Current Liabilities | 16,057 | 9,040 |
Convertible note payable-Related party | 164,994 | 164,994 |
TOTAL LIABILITIES | 181,051 | 174,034 |
STOCKHOLDERS' DEFICIT | ' | ' |
Preferred stock ($.001 par value, 50,000,000 shares authorized; none issued and outstanding) | ' | ' |
Common stock ($.001 par value, 100,000,000 shares authorized, 33,570,000 shares issued and outstanding at October 31, 2014 and January 31, 2014) | 33,570 | 33,570 |
Additional paid-In capital | 1,943,408 | 1,892,024 |
Accumulated deficit | -2,158,014 | -2,099,537 |
Total Stockholders' Deficit | -181,036 | -173,943 |
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $15 | $91 |
BALANCE_SHEETS_Parenthetical
BALANCE SHEETS (Parenthetical) (USD $) | Oct. 31, 2014 | Jan. 31, 2014 |
STOCKHOLDERS' DEFICIT | ' | ' |
Preferred stock, par value | $0.00 | $0.00 |
Preferred stock, Authorized | 50,000,000 | 50,000,000 |
Preferred stock, Issued | 0 | 0 |
Preferred stock, outstanding | 0 | 0 |
Common stock, par value | $0.00 | $0.00 |
Common stock, Authorized | 100,000,000 | 100,000,000 |
Common stock, Issued | 33,570,000 | 33,570,000 |
Common stock, outstanding | 33,570,000 | 33,570,000 |
STATEMENTS_OF_OPERATIONS_UNAUD
STATEMENTS OF OPERATIONS (UNAUDITED) (USD $) | 3 Months Ended | 9 Months Ended | ||
Oct. 31, 2014 | Oct. 31, 2013 | Oct. 31, 2014 | Oct. 31, 2013 | |
Statements Of Operations | ' | ' | ' | ' |
Compensation Costs | $15,865 | $15,869 | $47,077 | $46,809 |
General and Administrative | 42 | 4,303 | 58 | 13,035 |
Professional Fees | 2,348 | 1,584 | 7,036 | 5,936 |
Total General & Administrative Expenses | 18,255 | 21,756 | 54,170 | 65,780 |
Loss from Operations | -18,255 | -21,756 | -54,170 | -65,780 |
Other Income (Expense): | ' | ' | ' | ' |
Interest Expense | -1,452 | ' | -4,307 | -2,350 |
Beneficial Conversion | ' | -164,944 | ' | -164,994 |
Net Loss | ($19,707) | ($186,750) | ($58,477) | ($233,124) |
Basic and Diluted Loss Per Share | $0 | ($0.01) | $0 | ($0.01) |
Weighted average number of common shares outstanding | 33,570,000 | 33,570,000 | 33,570,000 | 33,570,000 |
STATEMENT_OF_STOCKHOLDERS_DEFI
STATEMENT OF STOCKHOLDERS' DEFICIT (USD $) | Common Stock | Additional Paid-In Capital | Accumulated Deficit | Total |
Beginning Balance, Amount at Feb. 02, 2005 | ' | ' | ' | ' |
Shares issued at inception, Shares | 100,000 | ' | ' | ' |
Shares issued at inception, Amount | $100 | $100 | ' | $200 |
Net Loss | ' | ' | -2,225 | -2,225 |
Ending Balance, Amount at Jan. 31, 2006 | 100 | 100 | -2,225 | -2,025 |
Ending Balance, Shares at Jan. 31, 2006 | 100,000 | ' | ' | ' |
Shares issued on acceptance of expenses paid on July 30, 2006, Shares | 275,000 | ' | ' | ' |
Shares issued on acceptance of expenses paid on July 30, 2006, Amount | 275 | 2,475 | ' | 2,750 |
Shares issued on acceptance of expenses paid on August 15, 2006, Shares | 1,250,000 | ' | ' | ' |
Shares issued on acceptance of expenses paid on August 15, 2006, Amount | 1,250 | 11,250 | ' | 12,500 |
Net Loss | ' | ' | -17,250 | -17,250 |
Ending Balance, Amount at Jan. 31, 2007 | 1,625 | 13,725 | -19,475 | -4,125 |
Ending Balance, Shares at Jan. 31, 2007 | 1,625,000 | ' | ' | ' |
Shares issued as compensation at $0.001 per share on November 1, 2007, Shares | 20,000,000 | ' | ' | ' |
Shares issued as compensation at $0.001 per share on November 1, 2007, Amount | 20,000 | 180,000 | ' | 200,000 |
Shares issued for cash at $0.025 per share during November 2007, Shares | 1,780,000 | ' | ' | ' |
Shares issued for cash at $0.025 per share during November 2007, Amount | 1,780 | 42,720 | ' | 44,500 |
Shares issued for cash at $0.025 per share on January 22, 2008, Shares | 40,000 | ' | ' | ' |
Shares issued for cash at $0.025 per share on January 22, 2008, Amount | 40 | 960 | ' | 1,000 |
Net Loss | ' | ' | -204,937 | -204,937 |
Ending Balance, Amount at Jan. 31, 2008 | 23,445 | 237,505 | -224,412 | 36,538 |
Ending Balance, Shares at Jan. 31, 2008 | 23,445,000 | ' | ' | ' |
Interest as in-kind contribution | ' | 534 | ' | 534 |
Shares issued as compensation at $0.16 per share on January 2, 2009, Shares | 1,125,000 | ' | ' | ' |
Shares issued as compensation at $0.16 per share on January 2, 2009, Amount | 1,125 | 178,875 | ' | 180,000 |
Net Loss | ' | ' | -270,426 | -270,426 |
Ending Balance, Amount at Jan. 31, 2009 | 24,570 | 416,914 | -494,838 | -53,354 |
Ending Balance, Shares at Jan. 31, 2009 | 24,570,000 | ' | ' | ' |
Interest as in-kind contribution | ' | 1,644 | ' | 1,644 |
Other expenses as in-kind contribution | ' | 6,275 | ' | 6,275 |
Net Loss | ' | ' | -26,654 | -26,654 |
Ending Balance, Amount at Jan. 31, 2010 | 24,570 | 424,833 | -521,492 | -72,089 |
Beginning Balance, Shares at Jan. 31, 2010 | 24,570,000 | ' | ' | ' |
Interest as in-kind contribution | ' | 2,358 | ' | 2,358 |
Shares issued as compensation at $0.16 per share on February 5, 2010, Shares | 4,000,000 | ' | ' | ' |
Shares issued as compensation at $0.16 per share on February 5, 2010, Amount | 4,000 | 636,000 | ' | 640,000 |
Net Loss | ' | ' | -669,200 | -669,200 |
Ending Balance, Amount at Jan. 31, 2011 | 28,570 | 1,063,191 | -1,190,692 | -98,931 |
Ending Balance, Shares at Jan. 31, 2011 | 28,570,000 | ' | ' | ' |
Interest as in-kind contribution | ' | 2,895 | ' | 2,895 |
Shares issued as compensation at $0.10 per share on June 30, 2011, Shares | 5,000,000 | ' | ' | ' |
Shares issued as compensation at $0.10 per share on June 30, 2011, Amount | 5,000 | 495,000 | ' | 500,000 |
Stock options issued as compensation at $0.10 per share on July 30, 2011 | ' | 31,933 | ' | 31,933 |
Net Loss | ' | ' | -562,448 | -562,448 |
Ending Balance, Amount at Jan. 31, 2012 | 33,570 | 1,593,019 | -1,753,140 | -126,551 |
Ending Balance, Shares at Jan. 31, 2012 | 33,570,000 | ' | ' | ' |
Interest as in-kind contribution | ' | 3,780 | ' | 3,780 |
Stock options expense | ' | 63,132 | ' | 63,132 |
Net Loss | ' | ' | -92,555 | -92,555 |
Ending Balance, Amount at Jan. 31, 2013 | 33,570 | 1,659,931 | -1,845,695 | -152,194 |
Ending Balance, Shares at Jan. 31, 2013 | 33,570,000 | ' | ' | ' |
Interest as in-kind contribution | ' | 4,207 | ' | 4,207 |
Stock options expense | ' | 62,892 | ' | 62,892 |
Beneficial conversion | ' | 164,994 | ' | 164,994 |
Net Loss | ' | ' | -253,842 | -253,842 |
Ending Balance, Amount at Jan. 31, 2014 | 33,570 | 1,892,024 | -2,099,537 | -173,943 |
Ending Balance, Shares at Jan. 31, 2014 | 33,570,000 | ' | ' | ' |
Interest as in-kind contribution | ' | 4,307 | ' | 4,307 |
Stock options expense | ' | 47,077 | ' | 47,077 |
Net Loss | ' | ' | -58,477 | -58,477 |
Ending Balance, Amount at Oct. 31, 2014 | $33,570 | $1,943,408 | ($2,158,014) | ($181,036) |
Ending Balance, Shares at Oct. 31, 2014 | 33,570,000 | ' | ' | ' |
STATEMENTS_OF_CASH_FLOWS
STATEMENTS OF CASH FLOWS (USD $) | 9 Months Ended | |
Oct. 31, 2014 | Oct. 31, 2013 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ' | ' |
Net loss | ($58,477) | ($233,124) |
Adjustments to reconcile net loss to net cash used in operating activities: | ' | ' |
Interest contribution to capital | 4,307 | 2,350 |
Stock options issued as compensation | ' | 46,809 |
Stock options issued for compensation | 47,077 | ' |
Amortization of beneficial conversion | ' | 164,994 |
Changes in operating assets and liabilities: | ' | ' |
Accounts payable and accrued expenses | 75 | 100 |
Shareholder advances | 6,942 | 18,825 |
Net cash (used by) provided by operating activities | -76 | -46 |
CASH FLOWS FROM INVESTING ACTIVITIES | ' | ' |
Net cash flows provided by (used in) investing activities | ' | ' |
CASH FLOWS FROM FINANCING ACTIVITIES | ' | ' |
Net cash flows provided by financing activities | ' | ' |
NET CHANGE IN CASH | -76 | -46 |
CASH BALANCE AT BEGINNING OF PERIOD | 91 | 50 |
CASH BALANCE AT END OF PERIOD | 15 | 4 |
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION: | ' | ' |
Interest paid | ' | ' |
Income taxes paid | ' | ' |
ORGANIZATION
ORGANIZATION | 9 Months Ended | ||
Oct. 31, 2014 | |||
Organization | ' | ||
Note 1. ORGANIZATION | ' | ||
Golden Opportunities Corporation (the “Company”), formally known as 51147, Inc. was incorporated in the state of Delaware on February 2, 2005. The Company was originally incorporated in order to locate and negotiate with a targeted business entity for the combination of that target company with The Company. The Company currently will leverage the talents of its sole executive and will implement its plan to become a business partner with an active company in the Services, Manufacturing, Financial or Public Relations market, i.e. assisting clients in their IPO and other types of fund raising activities (the “Affiliated Partner(s)”). | |||
In doing so, the Company will not need to merge into nor will it be required to acquire clients or services in order to engage in active business. The Company will establish its initial offices in Hong Kong and/or Shenzhen, China in an effort to expand into Asia’s emerging markets. | |||
The comprehensive scope of the Company’s professional services (the “Plan of Operations”) will include: | |||
- | Professional strategic analysis and recommendation; | ||
- | Professional legal or human resources provision; | ||
- | Professional strategic corporate consulting; | ||
- | Formulation of overall corporate growth or IPO strategy; | ||
- | Execution of investor relations campaigns; | ||
- | Formulation of media promotion strategy; | ||
- | Road show organization; | ||
- | Formulation of contingency liquidation solutions; and, | ||
- | Preparation of corporate promotional materials. | ||
Michael Zahorik is the sole officer and director, and has an operational background in the legal, securities, financial, and corporate industries. Mr. Zahorik has been actively consulting in Asia since 1989 and is managing director of Zahorik Professional Group. Mr. Zahorik has extensive knowledge, contacts and a professional network in the corporate and financial services industry within Hong Kong, Mainland China and other Asian emerging markets, including, Macau, Malaysia, Philippines, Singapore, Thailand and Vietnam (collectively, but not exclusively, the “Emerging Markets”). | |||
The financial statements have been prepared in conformity with generally accepted accounting principles in the United States. | |||
We have not generated any operating revenue and have a negative cash flow from operations. We expect to generate operating losses during some or all of our planned development stage. These factors raise substantial doubt about our ability to continue as a going concern. In view of these matters, our ability to continue as a going concern is dependent upon our ability to meet our financial requirements, raise additional capital, and the success of our future operations. |
SUMMARY_OF_SIGNIFICANT_ACCONTI
SUMMARY OF SIGNIFICANT ACCONTING POLICIES | 9 Months Ended | ||||
Oct. 31, 2014 | |||||
Summary Of Significant Acconting Policies | ' | ||||
Note 2. SUMMARY OF SIGNIFICANT ACCONTING POLICIES | ' | ||||
Basis of presentation | |||||
The financial statements and related disclosures have been prepared pursuant to the rules and regulations of the SEC. The financial statements have been prepared using the accrual basis of accounting in accordance with Generally Accepted Accounting Principles (“GAAP”) of the United States (See Note 3 regarding the assumption that the Company is a “going concern”). | |||||
The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, these condensed financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These financial statements should be read in conjunction with the financial statements for the year ended January 31, 2014 and notes thereto and other pertinent information contained in our Form 10-K the Company has filed with the Securities and Exchange Commission (the “SEC”). | |||||
The results of operations for the nine month period ended October 31, 2014 are not necessarily indicative of the results for the full fiscal year ending January 31, 2015. | |||||
Use of estimates | |||||
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. | |||||
Fiscal year end | |||||
The Company upon its formation elected January 31 as its fiscal year. | |||||
Cash equivalents | |||||
The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents. Cash and cash equivalents were $15 and $4 at October 31 and January 31, 2014, respectively. | |||||
The Company follows ASC 230, Statement of Cash Flows, for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by ASC 230 to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments. The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing and financing activities not resulting in cash receipts or payments in the period. | |||||
Commitments and contingencies | |||||
The Company follows ASC 450-20, Loss Contingencies, to report accounting for contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. There were no commitments or contingencies at October 31 and January 31, 2014. | |||||
Fair value of financial instruments | |||||
The Company’s balance sheet includes certain financial instruments: cash; accounts payable; accrued expenses; amounts due to shareholder; and convertible notes payable. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization. | |||||
ASC 820, Fair Value Measurements and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below: | |||||
Level 1 | Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. | ||||
Level 2 | Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. | ||||
Level 3 | Pricing inputs that are generally observable inputs and not corroborated by market data. | ||||
Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of October 31, 2014. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. | |||||
Deferred Income taxes and valuation allowance | |||||
We follow ASC 740, Income Taxes. We record deferred tax assets and liabilities for future income tax consequences that are attributable to differences between financial statement carrying amounts of assets and liabilities and their income tax bases. The measurement of deferred tax assets and liabilities is based on enacted tax rates that are expected to apply to taxable income in the year when settlement or recovery of those temporary differences is expected to occur. We recognize the effect on deferred tax assets and liabilities of any change in income tax rates in the period that includes the enactment date. We record a valuation allowance to reduce deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized. | |||||
A tax benefit from an uncertain tax position may be recognized only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities. The determination is based on the technical merits of the position and presumes that the relevant taxing authority that has full knowledge of all relevant information will examine each uncertain tax position. Although we believe the estimates are reasonable, no assurance can be given that the final outcome of these matters will not be different than what is reflected in the historical income tax provisions and accruals. | |||||
There were no recognized deferred tax assets or liabilities at July 31 or January 31, 2014. | |||||
Earnings (Loss) per share | |||||
The Company computes basic and diluted earnings per share amounts in accordance with ASC Topic 260, Earnings per Share. Basic earnings per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock that could share in the earnings of the Company. | |||||
The following table shows the number of potentially outstanding dilutive shares excluded from the diluted net loss per share calculation for the period from February 2, 2005 (inception) through October 31, 2014 as they were anti-dilutive. | |||||
Number of potentially outstanding | |||||
dilutive shares | |||||
For the Period from February 2, 2005 (inception) through October 31, 2014 | |||||
Stock options issued on July 30, 2011 to the officer of the Company with an exercise price of $0.10 per share expiring (8) years from the date of issuance | 8,000,000 | ||||
Total potentially outstanding dilutive shares | 8,000,000 | ||||
Related parties | |||||
The Company follows ASC 850, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions. (See Note 4, Related Party Transactions.) | |||||
Share-based expense | |||||
ASC 718, Compensation – Stock Compensation, prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). | |||||
All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instruments issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur. | |||||
The fair value of share options or similar instrument awards is estimated on the date of grant using a Black-Scholes option-pricing valuation model. The ranges of assumptions for inputs are as follows: | |||||
· | Expected term of share options and similar instruments: Pursuant to Paragraph 718-10-50-2 of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and employees’ expected exercise and post-vesting employment termination behavior into the fair value (or calculated value) of the instruments. The Company will use historical data to estimate employee termination behavior. The contractual term of share options or similar instruments is used as expected term of share options or similar instruments for the Company if it is a thinly traded public entity. | ||||
· | Expected volatility of the entity’s shares and the method used to estimate it. An entity that uses a method that employs different volatilities during the contractual term shall disclose the range of expected volatilities used and the weighted-average expected volatility. A thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for it to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index. The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility. If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market. | ||||
· | Expected dividends. An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends. The expected dividend yield is based on the Company’s current dividend yield as the best estimate of projected dividend yield for periods within the expected contractual life of the option. | ||||
· | Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the option. | ||||
The Company’s policy is to recognize compensation cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service period for the entire award. | |||||
The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, Equity –based Payments to Non-Employees. Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date. | |||||
Share-based expense for the periods ended October 31 and January 31, 2014 was $0. | |||||
Recently Issued Accounting Pronouncements | |||||
From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption. | |||||
Except for rules and interpretive releases of the SEC under authority of federal securities laws and a limited number of grandfathered standards, the FASB Accounting Standards Codification™ (“ASC”) is the sole source of authoritative GAAP literature recognized by the FASB and applicable to the Company. Management has reviewed the aforementioned rules and releases and believes any effect will not have a material impact on the Company’s present or future financial statements. | |||||
In August 2014, FASB issued Accounting Standards Update (ASU) No. 2014-15, Presentation of Financial Statements – Going Concern; Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The amendments in this update provide guidance in GAAP about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. In doing so, the amendments should reduce diversity in the timing and content of footnote disclosures. The guidance is effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early adoption is permitted but not required; at this time we are not early adopting. As the objective of this accounting standard is to provide guidance on the disclosure of uncertainties about an entity’s ability to continue as a going concern, the adoption of this standard is not expected to impact our financial position or results of operations. | |||||
In June 2014, FASB issued Accounting Standards Update (ASU) No. 2014-12 Compensation — Stock Compensation (Topic 718), Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. A performance target in a share-based payment that affects vesting and that could be achieved after the requisite service period should be accounted for as a performance condition under Accounting Standards Codification (ASC) 718, Compensation — Stock Compensation. As a result, the target is not reflected in the estimation of the award’s grant date fair value. Compensation cost would be recognized over the required service period, if it is probable that the performance condition will be achieved. The guidance is effective for annual periods beginning after December 15, 2015 and interim periods within those annual periods. Early adoption is permitted. Management has reviewed the ASU and believes that they currently account for these awards in a manner consistent with the new guidance, therefore, there is no expected impact on our financial statements or results of operations. | |||||
In June 2014, the FAAB issued ASU 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation. The amendments in this update remove all incremental financial reporting requirements from U.S. GAAP for development stage entities and also eliminate an exception provided to development stage entities in Topic 810, Consolidation, for determining whether an entity is a variable interest entity on the basis of the amount of investment equity that is at risk. These amendments are effective for annual reporting periods beginning after December 15, 2014, and interim periods therein, with early application permitted. Early application of each of the amendments is permitted for any annual reporting period or interim period for which the entity’s financial statements have not yet been issued (public business entities) or made available for issuance (other entities). We early adopted this pronouncement in the period ended July 31, 2014. As the objective of the amendments in this update is to improve financial reporting by reducing the cost and complexity associated with the incremental reporting requirements for development stage entities our early adoption of this guidance has not impacted our financial position or results of operations. |
GOING_CONCERN
GOING CONCERN | 9 Months Ended |
Oct. 31, 2014 | |
Going Concern | ' |
Note 3. GOING CONCERN | ' |
As reflected in the accompanying financial statements, the Company has earned no revenues and at October 31, 2014 had accumulated a deficit of $2,158,014. The Company had a current period net loss of $58,477 and cash used by operating activities of $76. | |
While the Company is attempting to commence operations and produce revenues, the Company’s cash position may not be significant enough to support the Company’s daily operations. Management intends to raise additional funds by way of a public or private offering. Management believes that the actions presently being taken to further implement its business plan and generate revenues provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to increase revenues and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate revenues. | |
The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. |
RELATED_PARTY_TRANSACTIONS
RELATED PARTY TRANSACTIONS | 9 Months Ended | ||||||||||||||||||||||||||||
Oct. 31, 2014 | |||||||||||||||||||||||||||||
Related Party Transactions | ' | ||||||||||||||||||||||||||||
Note 4. RELATED PARTY TRANSACTIONS | ' | ||||||||||||||||||||||||||||
Shareholder Advances | |||||||||||||||||||||||||||||
During the period ended October 31, 2014 the Company’s sole officer/principal owner advanced a total of $6,942. | |||||||||||||||||||||||||||||
Shareholder advances totalled $14,442 and $7,500 at October 31 and January 31, 2014, respectively. | |||||||||||||||||||||||||||||
Convertible Notes Payable | |||||||||||||||||||||||||||||
On September 15, 2013, $164,994 of shareholder loans payable to the Company’s sole officer/principal owner were re-structured into two notes in equal amounts of $82,497, convertible into the Company’s common stock at rates of $0.005 and $0.01 per share respectively. They are payable on demand, bear no interest, have a maturity date of September 15, 2023, and are convertible at the sole request of the holder/related party. Interest is imputed at the applicable federal rate of the origination date (3.49%) and recorded as contributed capital. | |||||||||||||||||||||||||||||
Based on the intrinsic value of the conversion feature, the Company determined that there was a beneficial conversion feature associated with two notes payable. As a result of the beneficial conversion feature exceeding the proceeds received from the promissory notes, management discounted the notes 100% and recognized a beneficial conversion expense of $164,994 on September 15, 2013. | |||||||||||||||||||||||||||||
Convertible notes payable totalled $164,994 at October 31 and January 31, 2014. Interest expense for the periods ended October 31, 2014 and 2013 was $4,307 and $2,350. | |||||||||||||||||||||||||||||
Equity – Common Stock | |||||||||||||||||||||||||||||
In 2005, the Company issued 100,000 shares, at $0.001 per share and totalling $200, to an officer of the company in exchange for expenses paid on behalf of the Company. | |||||||||||||||||||||||||||||
On July 30, 2006, the Company issued 275,000 shares, at $0.01 per share and totalling $2,750, to an officer of the company in in exchange for expenses paid on behalf of the Company. | |||||||||||||||||||||||||||||
On August 15, 2006, the Company issued 1,250,000 shares, at $0.01 per share and totalling $12,500, to an officer of the company in in exchange for expenses paid on behalf of the Company. | |||||||||||||||||||||||||||||
On November 1, 2007, the Company issued 3,000,000 shares, at $0.01 per share and totalling $30,000, to an officer of the company for compensation. | |||||||||||||||||||||||||||||
On November 1, 2007, the Company issued 700,000 shares, at $0.01 per share and totalling $7,000, to a related party in exchange for services rendered. | |||||||||||||||||||||||||||||
On November 1, 2007, the Company issued 16,300,000 shares, at $0.01 per share and totalling $163,000, as compensation to an officer of the Company. | |||||||||||||||||||||||||||||
On January 2, 2009, the Company issued 1,125,000 shares, at $0.16 per share and totalling $180,000 as compensation to an officer of the Company. | |||||||||||||||||||||||||||||
On February 5, 2010, the Company issued 4,000,000 shares, at $0.16 per share and totalling $640,000, as compensation to an officer of the Company. | |||||||||||||||||||||||||||||
On June 30, 2011, the Company issued 5,000,000 shares, at $0.10 per share and totalling $500,000, as compensation to an officer of the Company. | |||||||||||||||||||||||||||||
Equity – Options | |||||||||||||||||||||||||||||
In 2011 the Company issued an option to purchase 8,000,000 common shares at $0.10 per share and having no value on the date of grant, to an officer of the company for compensation. See Note 5, Stockholders’ Equity – Options. | |||||||||||||||||||||||||||||
Summary of Compensation Expense-Options | |||||||||||||||||||||||||||||
Date | Projected Fair | Expense | Expense | True-up | Cumulative Reported | Unrecognized Compensation | Weighted Average Period to Recognize Unrecognized Compensation Years | ||||||||||||||||||||||
Value on Date of Grant | Reported | projected | Amount | Expense | |||||||||||||||||||||||||
7/30/11 | 504,024 | 504,024 | 7 | ||||||||||||||||||||||||||
1/31/12 | 16,053 | 31,933 | 472,091 | 6.5 | |||||||||||||||||||||||||
1/31/13 | 61,132 | (43 | ) | 95,065 | 408,959 | 5.5 | |||||||||||||||||||||||
1/31/14 | 62,891 | 43 | 157,957 | 346,067 | 4.5 | ||||||||||||||||||||||||
10/31/14 | 47,077 | 205,034 | 298,990 | 3.75 | |||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||
The Company has been provided office space by its Chief Executive Officer at no cost. The management determined that such cost is nominal and did not recognize the rent expense in its financial statements. |
STOCKHOLDERS_EQUITY
STOCKHOLDERS' EQUITY | 9 Months Ended | ||||||||||||||||||||
Oct. 31, 2014 | |||||||||||||||||||||
Stockholders Equity | ' | ||||||||||||||||||||
Note 5. STOCKHOLDERS' EQUITY | ' | ||||||||||||||||||||
Preferred stock | |||||||||||||||||||||
Preferred stock totals 50,000,000 shares authorized at a par value of $0.001, of which none are issued or outstanding. | |||||||||||||||||||||
Common stock | |||||||||||||||||||||
Equity –Common Stock | |||||||||||||||||||||
On February 2, 2005, the Company issued 100,000 shares, at $0.001 per share and totalling $200, to its President in exchange for incorporation expenses paid on behalf of the Company. | |||||||||||||||||||||
On June 30, 2006, the Company issued 275,000 shares, at $0.01 per share and totalling $2,750, to its President in exchange for general and administrative expenses paid on behalf of the Company. | |||||||||||||||||||||
On August 15, 2006, the Company issued 1,250,000 shares, at $0.01 per share and totalling $12,500, to its President in exchange for general and administrative expenses paid on behalf of the Company. | |||||||||||||||||||||
On November 1, 2007, the Company issued 19,300,000 shares, at $0.01 per share and totalling $193,000, as compensation to an officer of the Company. | |||||||||||||||||||||
On November 1, 2007, the Company issued 700,000 shares at $0.01 per share, and totalling $7,000, to a related party in exchange for services rendered. | |||||||||||||||||||||
On January 2, 2009, the Company issued 1,125,000 shares, at $0.16 per share and totalling $180,000, as compensation to an officer of the Company. | |||||||||||||||||||||
On February 5, 2010, the Company issued 4,000,000 shares, at $0.16 per share and totalling $640,000, as compensation to an officer of the Company. | |||||||||||||||||||||
On June 30, 2011, the Company issued 5,000,000 shares, at $0.10 per share and totalling $500,000 as compensation to an officer of the Company. | |||||||||||||||||||||
Stock options | |||||||||||||||||||||
On July 30, 2011, the Company issued an option to purchase 8,000,000 common shares to an officer of the Company in consideration for services at $0.10 per share valued at nil on the date of grant as compensation. | |||||||||||||||||||||
The fair value of the option grant estimated on the date of grant uses the Black-Scholes option-pricing model with the following weighted-average assumptions: | |||||||||||||||||||||
30-Jul-11 | |||||||||||||||||||||
Expected option life (year) | 8 | ||||||||||||||||||||
Expected volatility | 58.62 | %* | |||||||||||||||||||
Expected dividends | 0 | % | |||||||||||||||||||
Risk-free rate(s) | 2.32 | % | |||||||||||||||||||
* As a thinly traded public entity, it is not practicable for it to estimate the expected volatility of its share price. The Company selected two (2) comparable companies to calculate the expected volatility. The Company calculated two (2) comparable companies’ historical volatility over the expect life of the share options of eight (8) years and averaged the two (2) comparable companies’ historical volatility as its expected volatility. | |||||||||||||||||||||
The fair value of the stock options issued on July 30, 2011 using the Black-Scholes Option Pricing Model was $504,024 at the date of grant. For the periods ended October 31, 2014 and 2013, $47,077 and $47,027, respectively, was recognized as compensation cost for stock options issued. | |||||||||||||||||||||
The table below summarizes the Company’s stock option activities through October 31, 2014: | |||||||||||||||||||||
Number of | Exercise Price Range Per Share | Weighted Average | Fair Value at Date of Grant | Aggregate Intrinsic Value | |||||||||||||||||
Option Shares | Exercise Price | ||||||||||||||||||||
Balance, February 1, 2013 | 8,000,000 | $ | 0.1 | $ | 0.1 | $ | 504,024 | $ | - | ||||||||||||
Granted | - | - | - | - | |||||||||||||||||
Canceled | - | - | - | - | |||||||||||||||||
Exercised | - | - | - | - | |||||||||||||||||
Expired | - | - | - | - | |||||||||||||||||
Balance, January 31, 2014 | 8,000,000 | $ | 0.1 | $ | 0.1 | $ | 504,024 | $ | - | ||||||||||||
Vested and exercisable, July 31, 2014 | 2,000,000 | $ | 0.1 | $ | 0.1 | - | $ | - | |||||||||||||
Unvested, October 31, 2014 | 6,000,000 | $ | 0.1 | $ | 0.1 | - | $ | - |
INCOME_TAXES
INCOME TAXES | 9 Months Ended | |||||||
Oct. 31, 2014 | ||||||||
Income Taxes | ' | |||||||
NOTE 6 - INCOME TAXES | ' | |||||||
The Company has not recognized an income tax benefit for its operating losses generated based on uncertainties concerning its ability to generate taxable income in future periods. The tax benefit for the periods presented is offset by a valuation allowance established against deferred tax assets arising from the net operating losses and other temporary differences, the realization of which could not be considered more likely than not. In future periods, tax benefits and related deferred tax assets will be recognized when management considers realization of such amounts to be more likely than not. | ||||||||
As of October 31, 2014 and 2013, the Company has incurred net losses of $2,158,015 and $2,078,819 resulting in net operating losses for income tax purposes. Under the Internal Revenue Code of 1986, as amended, these losses can be carried forward twenty years. As of October 31, 2014 the Company has net operating loss carry forwards, which begin expiring in 2025. The loss results in a deferred tax asset of approximately $323,700 at the effective statutory rate of 15%. The deferred tax asset has been off-set by an equal valuation allowance. | ||||||||
October 31, | ||||||||
2014 | 2013 | |||||||
Deferred tax asset, generated from net operating loss at statutory rates | $ | 323,700 | $ | 311,800 | ||||
Valuation allowance | (323,700 | ) | (311,800 | ) | ||||
$ | — | $ | — | |||||
The reconciliation of the effective income tax rate to the federal statutory rate is as follows: | ||||||||
Federal income tax rate | 15 | % | ||||||
Increase in valuation allowance | (15.0 | %) | ||||||
Effective income tax rate | 0 | % | ||||||
The Company has not taken any uncertain tax positions, however, has open tax years subject to audit by the Internal Revenue Services, for the years beginning in 2011. |
SUBSEQUENT_EVENTS
SUBSEQUENT EVENTS | 9 Months Ended |
Oct. 31, 2014 | |
Subsequent Events | ' |
Note 7. SUBSEQUENT EVENTS | ' |
Management has evaluated subsequent events through the date the financial statements were issued. Based on our evaluation no events have occurred requiring adjustment or disclosure. |
SUMMARY_OF_SIGNIFICANT_ACCONTI1
SUMMARY OF SIGNIFICANT ACCONTING POLICIES (Policies) | 9 Months Ended | ||||
Oct. 31, 2014 | |||||
Summary Of Significant Acconting Policies Policies | ' | ||||
Basis of presentation | ' | ||||
The financial statements and related disclosures have been prepared pursuant to the rules and regulations of the SEC. The financial statements have been prepared using the accrual basis of accounting in accordance with Generally Accepted Accounting Principles (“GAAP”) of the United States (See Note 3 regarding the assumption that the Company is a “going concern”). | |||||
The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, these condensed financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These financial statements should be read in conjunction with the financial statements for the year ended January 31, 2014 and notes thereto and other pertinent information contained in our Form 10-K the Company has filed with the Securities and Exchange Commission (the “SEC”). | |||||
The results of operations for the nine month period ended October 31, 2014 are not necessarily indicative of the results for the full fiscal year ending January 31, 2015. | |||||
Use of estimates | ' | ||||
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. | |||||
Fiscal year end | ' | ||||
The Company upon its formation elected January 31 as its fiscal year. | |||||
Cash equivalents | ' | ||||
The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents. Cash and cash equivalents were $15 and $4 at October 31 and January 31, 2014, respectively. | |||||
The Company follows ASC 230, Statement of Cash Flows, for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by ASC 230 to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments. The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing and financing activities not resulting in cash receipts or payments in the period. | |||||
Commitments and contingencies | ' | ||||
The Company follows ASC 450-20, Loss Contingencies, to report accounting for contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. There were no commitments or contingencies at October 31 and January 31, 2014. | |||||
Fair value of financial instruments | ' | ||||
The Company’s balance sheet includes certain financial instruments: cash; accounts payable; accrued expenses; amounts due to shareholder; and convertible notes payable. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization. | |||||
ASC 820, Fair Value Measurements and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below: | |||||
Level 1 | Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. | ||||
Level 2 | Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. | ||||
Level 3 | Pricing inputs that are generally observable inputs and not corroborated by market data. | ||||
Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of October 31, 2014. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. | |||||
Deferred Income taxes and valuation allowance | ' | ||||
We follow ASC 740, Income Taxes. We record deferred tax assets and liabilities for future income tax consequences that are attributable to differences between financial statement carrying amounts of assets and liabilities and their income tax bases. The measurement of deferred tax assets and liabilities is based on enacted tax rates that are expected to apply to taxable income in the year when settlement or recovery of those temporary differences is expected to occur. We recognize the effect on deferred tax assets and liabilities of any change in income tax rates in the period that includes the enactment date. We record a valuation allowance to reduce deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized. | |||||
A tax benefit from an uncertain tax position may be recognized only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities. The determination is based on the technical merits of the position and presumes that the relevant taxing authority that has full knowledge of all relevant information will examine each uncertain tax position. Although we believe the estimates are reasonable, no assurance can be given that the final outcome of these matters will not be different than what is reflected in the historical income tax provisions and accruals. | |||||
There were no recognized deferred tax assets or liabilities at July 31 or January 31, 2014. | |||||
Earnings (Loss) per share | ' | ||||
The Company computes basic and diluted earnings per share amounts in accordance with ASC Topic 260, Earnings per Share. Basic earnings per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock that could share in the earnings of the Company. | |||||
The following table shows the number of potentially outstanding dilutive shares excluded from the diluted net loss per share calculation for the period from February 2, 2005 (inception) through October 31, 2014 as they were anti-dilutive. | |||||
Number of potentially outstanding | |||||
dilutive shares | |||||
For the Period from February 2, 2005 (inception) through October 31, 2014 | |||||
Stock options issued on July 30, 2011 to the officer of the Company with an exercise price of $0.10 per share expiring (8) years from the date of issuance | 8,000,000 | ||||
Total potentially outstanding dilutive shares | 8,000,000 | ||||
Related parties | ' | ||||
The Company follows ASC 850, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions. (See Note 4, Related Party Transactions.) | |||||
Share-based Expense | ' | ||||
ASC 718, Compensation – Stock Compensation, prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). | |||||
All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instruments issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur. | |||||
The fair value of share options or similar instrument awards is estimated on the date of grant using a Black-Scholes option-pricing valuation model. The ranges of assumptions for inputs are as follows: | |||||
· | Expected term of share options and similar instruments: Pursuant to Paragraph 718-10-50-2 of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and employees’ expected exercise and post-vesting employment termination behavior into the fair value (or calculated value) of the instruments. The Company will use historical data to estimate employee termination behavior. The contractual term of share options or similar instruments is used as expected term of share options or similar instruments for the Company if it is a thinly traded public entity. | ||||
· | Expected volatility of the entity’s shares and the method used to estimate it. An entity that uses a method that employs different volatilities during the contractual term shall disclose the range of expected volatilities used and the weighted-average expected volatility. A thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for it to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index. The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility. If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market. | ||||
· | Expected dividends. An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends. The expected dividend yield is based on the Company’s current dividend yield as the best estimate of projected dividend yield for periods within the expected contractual life of the option. | ||||
· | Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the option. | ||||
The Company’s policy is to recognize compensation cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service period for the entire award. | |||||
The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, Equity –based Payments to Non-Employees. Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date. | |||||
Share-based expense for the periods ended October 31 and January 31, 2014 was $0. | |||||
Recently Issued Accounting Pronouncements | ' | ||||
From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption. | |||||
Except for rules and interpretive releases of the SEC under authority of federal securities laws and a limited number of grandfathered standards, the FASB Accounting Standards Codification™ (“ASC”) is the sole source of authoritative GAAP literature recognized by the FASB and applicable to the Company. Management has reviewed the aforementioned rules and releases and believes any effect will not have a material impact on the Company’s present or future financial statements. | |||||
In August 2014, FASB issued Accounting Standards Update (ASU) No. 2014-15, Presentation of Financial Statements – Going Concern; Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The amendments in this update provide guidance in GAAP about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. In doing so, the amendments should reduce diversity in the timing and content of footnote disclosures. The guidance is effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early adoption is permitted but not required; at this time we are not early adopting. As the objective of this accounting standard is to provide guidance on the disclosure of uncertainties about an entity’s ability to continue as a going concern, the adoption of this standard is not expected to impact our financial position or results of operations. | |||||
In June 2014, FASB issued Accounting Standards Update (ASU) No. 2014-12 Compensation — Stock Compensation (Topic 718), Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. A performance target in a share-based payment that affects vesting and that could be achieved after the requisite service period should be accounted for as a performance condition under Accounting Standards Codification (ASC) 718, Compensation — Stock Compensation. As a result, the target is not reflected in the estimation of the award’s grant date fair value. Compensation cost would be recognized over the required service period, if it is probable that the performance condition will be achieved. The guidance is effective for annual periods beginning after December 15, 2015 and interim periods within those annual periods. Early adoption is permitted. Management has reviewed the ASU and believes that they currently account for these awards in a manner consistent with the new guidance, therefore, there is no expected impact on our financial statements or results of operations. | |||||
In June 2014, the FAAB issued ASU 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation. The amendments in this update remove all incremental financial reporting requirements from U.S. GAAP for development stage entities and also eliminate an exception provided to development stage entities in Topic 810, Consolidation, for determining whether an entity is a variable interest entity on the basis of the amount of investment equity that is at risk. These amendments are effective for annual reporting periods beginning after December 15, 2014, and interim periods therein, with early application permitted. Early application of each of the amendments is permitted for any annual reporting period or interim period for which the entity’s financial statements have not yet been issued (public business entities) or made available for issuance (other entities). We early adopted this pronouncement in the period ended July 31, 2014. As the objective of the amendments in this update is to improve financial reporting by reducing the cost and complexity associated with the incremental reporting requirements for development stage entities our early adoption of this guidance has not impacted our financial position or results of operations. |
SUMMARY_OF_SIGNIFICANT_ACCONTI2
SUMMARY OF SIGNIFICANT ACCONTING POLICIES (Tables) | 9 Months Ended | ||||
Oct. 31, 2014 | |||||
Summary Of Significant Acconting Policies Tables | ' | ||||
Number of potentially outstanding dilutive shares | ' | ||||
The following table shows the number of potentially outstanding dilutive shares excluded from the diluted net loss per share calculation for the period from February 2, 2005 (inception) through October 31, 2014 as they were anti-dilutive. | |||||
Number of potentially outstanding | |||||
dilutive shares | |||||
For the Period from February 2, 2005 (inception) through October 31, 2014 | |||||
Stock options issued on July 30, 2011 to the officer of the Company with an exercise price of $0.10 per share expiring (8) years from the date of issuance | 8,000,000 | ||||
Total potentially outstanding dilutive shares | 8,000,000 |
RELATED_PARTY_TRANSACTIONS_Tab
RELATED PARTY TRANSACTIONS (Tables) | 9 Months Ended | ||||||||||||||||||||||||||||
Oct. 31, 2014 | |||||||||||||||||||||||||||||
Related Party Transactions Tables | ' | ||||||||||||||||||||||||||||
Summary of compensation expense | ' | ||||||||||||||||||||||||||||
Date | Projected Fair | Expense | Expense | True-up | Cumulative Reported | Unrecognized Compensation | Weighted Average Period to Recognize Unrecognized Compensation Years | ||||||||||||||||||||||
Value on Date of Grant | Reported | projected | Amount | Expense | |||||||||||||||||||||||||
7/30/11 | 504,024 | 504,024 | 7 | ||||||||||||||||||||||||||
1/31/12 | 16,053 | 31,933 | 472,091 | 6.5 | |||||||||||||||||||||||||
1/31/13 | 61,132 | (43 | ) | 95,065 | 408,959 | 5.5 | |||||||||||||||||||||||
1/31/14 | 62,891 | 43 | 157,957 | 346,067 | 4.5 | ||||||||||||||||||||||||
10/31/14 | 47,077 | 205,034 | 298,990 | 3.75 |
STOCKHOLDERS_EQUITY_Tables
STOCKHOLDERS' EQUITY (Tables) | 9 Months Ended | ||||||||||||||||||||
Oct. 31, 2014 | |||||||||||||||||||||
Stockholders Equity Tables | ' | ||||||||||||||||||||
Fair value of the option grant | ' | ||||||||||||||||||||
The fair value of the option grant estimated on the date of grant uses the Black-Scholes option-pricing model with the following weighted-average assumptions: | |||||||||||||||||||||
30-Jul-11 | |||||||||||||||||||||
Expected option life (year) | 8 | ||||||||||||||||||||
Expected volatility | 58.62 | %* | |||||||||||||||||||
Expected dividends | 0 | % | |||||||||||||||||||
Risk-free rate(s) | 2.32 | % | |||||||||||||||||||
Stock option activities | ' | ||||||||||||||||||||
The table below summarizes the Company’s stock option activities through October 31, 2014: | |||||||||||||||||||||
Number of | Exercise Price Range Per Share | Weighted Average | Fair Value at Date of Grant | Aggregate Intrinsic Value | |||||||||||||||||
Option Shares | Exercise Price | ||||||||||||||||||||
Balance, February 1, 2013 | 8,000,000 | $ | 0.1 | $ | 0.1 | $ | 504,024 | $ | - | ||||||||||||
Granted | - | - | - | - | |||||||||||||||||
Canceled | - | - | - | - | |||||||||||||||||
Exercised | - | - | - | - | |||||||||||||||||
Expired | - | - | - | - | |||||||||||||||||
Balance, January 31, 2014 | 8,000,000 | $ | 0.1 | $ | 0.1 | $ | 504,024 | $ | - | ||||||||||||
Vested and exercisable, July 31, 2014 | 2,000,000 | $ | 0.1 | $ | 0.1 | - | $ | - | |||||||||||||
Unvested, October 31, 2014 | 6,000,000 | $ | 0.1 | $ | 0.1 | - | $ | - |
INCOME_TAXES_Tables
INCOME TAXES (Tables) | 9 Months Ended | |||||||
Oct. 31, 2014 | ||||||||
Income Taxes | ' | |||||||
Deferred tax assets | ' | |||||||
October 31, | ||||||||
2014 | 2013 | |||||||
Deferred tax asset, generated from net operating loss at statutory rates | $ | 323,700 | $ | 311,800 | ||||
Valuation allowance | (323,700 | ) | (311,800 | ) | ||||
$ | — | $ | — | |||||
Reconciliation of the effective income tax rate to the federal statutory rate | ' | |||||||
Federal income tax rate | 15 | % | ||||||
Increase in valuation allowance | (15.0 | %) | ||||||
Effective income tax rate | 0 | % |
ORGANIZATION_Details_Narrative
ORGANIZATION (Details Narrative) | 9 Months Ended |
Oct. 31, 2014 | |
Organization Details Narrative | ' |
Company incorporation state | 'State of Delaware |
Company Incorporation Date | 2-Feb-05 |
SUMMARY_OF_SIGNIFICANT_ACCONTI3
SUMMARY OF SIGNIFICANT ACCONTING POLICIES (Details) | 117 Months Ended |
Oct. 31, 2014 | |
Summary Of Significant Acconting Policies Details | ' |
Stock options issued on July 30, 2011 to the officer of the Company with an exercise price of $0.10 per share expiring eight (8) years from the date of issuance | 8,000,000 |
Total potentially outstanding dilutive shares | 8,000,000 |
SUMMARY_OF_SIGNIFICANT_ACCONTI4
SUMMARY OF SIGNIFICANT ACCONTING POLICIES (Details Narrative) (USD $) | 9 Months Ended | 12 Months Ended |
Oct. 31, 2014 | Jan. 31, 2014 | |
Summary Of Significant Acconting Policies Details Narrative | ' | ' |
Cash and cash equivalents | $15 | $4 |
Share-based expense | $0 | $0 |
GOING_CONCERN_Details_Narrativ
GOING CONCERN (Details Narrative) (USD $) | 9 Months Ended | 12 Months Ended | |||||||||
Oct. 31, 2014 | Oct. 31, 2013 | Jan. 31, 2014 | Jan. 31, 2013 | Jan. 31, 2012 | Jan. 31, 2011 | Jan. 31, 2010 | Jan. 31, 2009 | Jan. 31, 2008 | Jan. 31, 2007 | Jan. 31, 2006 | |
Going Concern Details Narrative | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Accumulated deficit | ($2,158,014) | ' | ($2,099,537) | ' | ' | ' | ' | ' | ' | ' | ' |
Net loss | -58,477 | ' | -253,842 | -92,555 | -562,448 | -669,200 | -26,654 | -270,426 | -204,937 | -17,250 | -2,225 |
Cash used in operations | ($76) | ($46) | ' | ' | ' | ' | ' | ' | ' | ' | ' |
RELATED_PARTY_TRANSACTIONS_Det
RELATED PARTY TRANSACTIONS (Details) (USD $) | 9 Months Ended |
Oct. 31, 2014 | |
Compensation Expense 1 [Member] | ' |
Compensation expense date | '7/30/2011 |
Projected Fair Value on Date of Grant | $504,024 |
Expense Reported | ' |
Expense Projected | ' |
True-Up Amount | ' |
Cumulative Reported Expense | ' |
Unrecognized Compensation | 504,024 |
Weighted Average Period to Recognize Unrecognized Compensation (years) | '7 years |
Compensation Expense 2 [Member] | ' |
Compensation expense date | '1/31/2012 |
Expense Reported | 16,053 |
Expense Projected | ' |
Cumulative Reported Expense | 31,933 |
Unrecognized Compensation | 472,091 |
Weighted Average Period to Recognize Unrecognized Compensation (years) | '6 years 6 months |
Compensation Expense 3 [Member] | ' |
Compensation expense date | '1/31/2013 |
Expense Reported | 61,132 |
Expense Projected | ' |
True-Up Amount | -43 |
Cumulative Reported Expense | 95,065 |
Unrecognized Compensation | 408,959 |
Weighted Average Period to Recognize Unrecognized Compensation (years) | '5 years 6 months |
Compensation Expense 4 [Member] | ' |
Compensation expense date | '1/31/2014 |
Expense Reported | 62,891 |
Expense Projected | ' |
True-Up Amount | 43 |
Cumulative Reported Expense | 157,957 |
Unrecognized Compensation | 346,067 |
Weighted Average Period to Recognize Unrecognized Compensation (years) | '4 years 6 months |
Compensation Expense 5 [Member] | ' |
Compensation expense date | '10/31/2014 |
Expense Reported | 15,347 |
Expense Projected | ' |
Cumulative Reported Expense | 205,034 |
Unrecognized Compensation | $298,990 |
Weighted Average Period to Recognize Unrecognized Compensation (years) | '3 years 9 months |
RELATED_PARTY_TRANSACTIONS_Det1
RELATED PARTY TRANSACTIONS (Details Narrative) (USD $) | 3 Months Ended | 9 Months Ended | |||
Oct. 31, 2014 | Oct. 31, 2013 | Oct. 31, 2014 | Oct. 31, 2013 | Jan. 31, 2014 | |
Related Party Transactions Details Narrative | ' | ' | ' | ' | ' |
Sole officer/principal owner advanced | ' | ' | $6,942 | $18,825 | ' |
Shareholder advances | 14,442 | ' | 14,442 | ' | 7,500 |
Convertible notes payable | 164,994 | ' | 164,994 | ' | 164,994 |
Interest Expense | $1,452 | ' | $4,307 | $2,350 | ' |
STOCKHOLDERS_EQUITY_Details
STOCKHOLDERS' EQUITY (Details) | 6 Months Ended |
Jul. 30, 2011 | |
Stockholders Equity Details | ' |
Expected option life (year) | '8 years |
Expected volatility | 58.62% |
Expected dividends | 0.00% |
Risk-free rate(s) | 2.32% |
STOCKHOLDERS_EQUITY_Details_1
STOCKHOLDERS' EQUITY (Details 1) (USD $) | 9 Months Ended | 12 Months Ended |
Oct. 31, 2014 | Jan. 31, 2014 | |
Number of Option Shares | ' | ' |
Balance Beginning, Number of Option Shares | 8,000,000 | 8,000,000 |
Granted, Number of Option Shares | ' | ' |
Canceled, Number of Option Shares | ' | ' |
Exercised, Number of Option Shares | ' | ' |
Expired, Number of Option Shares | ' | ' |
Balance Ending, Number of Option Shares | ' | 8,000,000 |
Vested and exercisable, July 31, 2014 Number of Option Shares | 2,000,000 | ' |
Unvested at Ending, Number of Option Shares | 6,000,000 | ' |
Exercise Price Range Per Share | ' | ' |
Balance Beginning Exercise Price Range Per Share | $0.10 | $0.10 |
Granted Exercise Price Range Per Share | ' | ' |
Canceled Exercise Price Range Per Share | ' | ' |
Exercised Exercise Price Range Per Share | ' | ' |
Expired Exercise Price Range Per Share | ' | ' |
Balance Ending Exercise Price Range Per Share | ' | $0.10 |
Vested and exercisable, July 31, 2014, Exercise Price Range Per Share | $0.10 | ' |
Unvested at Ending Exercise Price Range Per Share | $0.10 | ' |
Weighted Average Exercise Price | ' | ' |
Balance Beginning Weighted Average Exercise Price | $0.10 | $0.10 |
Granted Weighted Average Exercise Price | ' | ' |
Canceled Weighted Average Exercise Price | ' | ' |
Exercised Weighted Average Exercise Price | ' | ' |
Expired Weighted Average Exercise Price | ' | ' |
Balance Ending Weighted Average Exercise Price | ' | $0.10 |
Vested and exercisable, July 31, 2014, Weighted Average Exercise Price | $0.10 | ' |
Unvested at Ending Weighted Average Exercise Price | $0.10 | ' |
Fair Value at Date of Grant | ' | ' |
Balance Beginning Fair Value at Date of Grant | $504,024 | $504,024 |
Granted Fair Value at Date of Grant | ' | ' |
Canceled Fair Value at Date of Grant | ' | ' |
Exercised Fair Value at Date of Grant | ' | ' |
Expired Fair Value at Date of Grant | ' | ' |
Balance Ending Fair Value at Date of Grant | ' | 504,024 |
Vested and exercisable, July 31, 2014, Fair Value at Date of Grant | ' | ' |
Unvested at Ending Fair Value at Date of Grant | ' | ' |
Aggregate Intrinsic Value | ' | ' |
Balance Beginning Aggregate Intrinsic Value | ' | ' |
Granted Aggregate Intrinsic Value | ' | ' |
Canceled Aggregate Intrinsic Value | ' | ' |
Exercised Aggregate Intrinsic Value | ' | ' |
Expired Aggregate Intrinsic Value | ' | ' |
Balance Ending Aggregate Intrinsic Value | ' | ' |
Vested and exercisable, July 31, 2014, Aggregate Intrinsic Value | ' | ' |
Unvested at Ending Aggregate Intrinsic Value | ' | ' |
STOCKHOLDERS_EQUITY_Details_Na
STOCKHOLDERS' EQUITY (Details Narrative) (USD $) | 9 Months Ended | ||
Oct. 31, 2014 | Oct. 31, 2013 | Jan. 31, 2014 | |
Stockholders Equity Details Narrative | ' | ' | ' |
Preferred Stock, Authorized shares | 50,000,000 | ' | 50,000,000 |
Preferred Stock, Par value | $0.00 | ' | $0.00 |
Preferred Stock, Issued shares | 0 | ' | 0 |
Preferred Stock, Outstanding shares | 0 | ' | 0 |
Compensation cost for stock options issued | $47,077 | $47,027 | ' |
INCOME_TAXES_Details
INCOME TAXES (Details) (USD $) | Oct. 31, 2014 | Oct. 31, 2013 |
Deferred tax assets: | ' | ' |
Deferred tax asset, generated from net operating loss at statutory rates | $323,700 | $311,800 |
Valuation allowance | -323,700 | -311,800 |
Total | ' | ' |
INCOME_TAXES_Details_2
INCOME TAXES (Details 2) | 9 Months Ended |
Oct. 31, 2014 | |
Income Taxes Details 2 | ' |
Federal income tax rate | 15.00% |
Increase in valuation allowance | -15.00% |
Effective income tax rate | 0.00% |
INCOME_TAXES_Details_Narrative
INCOME TAXES (Details Narrative) (USD $) | 9 Months Ended | |
Oct. 31, 2014 | Oct. 31, 2013 | |
Income Taxes | ' | ' |
Operating loss carry - forwards, Net | $2,158,015 | $2,078,819 |
Expiry date | '2025 | ' |